# AGIOS PHARMACEUTICALS, INC. (AGIO) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from AGIOS PHARMACEUTICALS, INC.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/AGIO/mda/fy2025/): filed 2026-02-12; accession 0001439222-26-000025 (https://www.sec.gov/Archives/edgar/data/1439222/000143922226000025/agio-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/AGIO/mda/fy2024/): filed 2025-02-13; accession 0001439222-25-000009 (https://www.sec.gov/Archives/edgar/data/1439222/000143922225000009/agio-20241231.htm)
- [FY 2023 MD&A](/company/AGIO/mda/fy2023/): filed 2024-02-15; accession 0001439222-24-000035 (https://www.sec.gov/Archives/edgar/data/1439222/000143922224000035/agio-20231231.htm)
- [FY 2022 MD&A](/company/AGIO/mda/fy2022/): filed 2023-02-23; accession 0001439222-23-000039 (https://www.sec.gov/Archives/edgar/data/1439222/000143922223000039/agio-20221231.htm)
- [FY 2021 MD&A](/company/AGIO/mda/fy2021/): filed 2022-02-24; accession 0001439222-22-000024 (https://www.sec.gov/Archives/edgar/data/1439222/000143922222000024/agio-20211231.htm)

Back to /company/AGIO/